MetaADEDB 2.0 @ LMMD
rebaudioside A
(HELXLJCILKEWJH-NCGAPWICSA-N)
Structure
SMILES
OC[C@H]1O[C@@H](O[C@@]23CC[C@@H]4[C@@](C2)(CC3=C)CC[C@H]2[C@@]4(C)CCC[C@@]2(C)C(=O)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O
Type(s)
Investigational
Molecular Formula:
C44H70O23
Molecular Weight:
967.013
Log P:
-5.1139
Hydrogen Bond Acceptor:
23
Hydrogen Bond Donor:
14
TPSA:
374.13
CAS Number(s):
58543-16-1; 91722-21-3
Synonym(s)
1.
rebaudioside A
2.
19-O-beta-glucopyranosyl-13-O-(beta-glucopyranosyl(1-2)-beta-glucopyranosyl(1-3))-beta-glucopyranosyl-13-hydroxykaur-16-en-19-oic acid
3.
19-O-beta-glucopyranosyl-13-O-(beta-glucopyranosyl(1-2)-beta-glucopyranosyl(1-3))-beta-glucopyranosylsteviol
External Link(s)
MeSHC025474
PubChem Compound6918840
ChEBI145012
DrugBankDB15136
ZINC242498440
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ChillsCanada Vigilance: 1Canada Vigilance
2DizzinessCanada Vigilance: 1Canada Vigilance
3Fatty Liver25554529CTD
4NauseaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.